Sunday, February 18, 2018

Novartis CEO Steers Drug Maker Back to R&D

Vasant Narasimhan, the 41-year-old chief executive at Novartis AG, is vowing data science and digital technologies will revolutionize the company’s drug-development pipeline.

from WSJ.com: US Business http://ift.tt/2BD0hUf
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)